Cenini, G., Dowling, A., Beckett, T., Barone, E., Mancuso, C., Murphy, M., … Head, E. (2012). Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochimica et Biophysica Acta, 1822(2), 130-8. https://doi.org/10.1016/j.bbadis.2011.10.001

Hardas, S., Sultana, R., Clark, A., Beckett, T., Szweda, L., Murphy, M., & Butterfield, D. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biology, 1, 80-5. https://doi.org/10.1016/j.redox.2013.01.002 (Original work published 2013)

Farr, S., Ripley, J., Sultana, R., Zhang, Z., Niehoff, M., Platt, T., … Butterfield, D. (2014). Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radical Biology & Medicine, 67, 387-95. https://doi.org/10.1016/j.freeradbiomed.2013.11.014

Stucki, D., Ruegsegger, C., Steiner, S., Radecke, J., Murphy, M., Zuber, B., & Saxena, S. (2016). Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ. Free Radical Biology & Medicine, 97, 427-440. https://doi.org/10.1016/j.freeradbiomed.2016.07.005

Sethi, M., Joshi, S., Webb, R., Beckett, T., Donohue, K., Murphy, M., … Duncan, M. (2015). Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer’s disease. Neuroscience, 290, 80-9. https://doi.org/10.1016/j.neuroscience.2015.01.035 (Original work published 2015)

Duncan, M., Smith, J., Franklin, K., Beckett, T., Murphy, M., St Clair, D., … O’Hara, B. (2012). Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer’s disease. Experimental Neurology, 236(2), 249-58. https://doi.org/10.1016/j.expneurol.2012.05.011

Barone, E., Cenini, G., Di Domenico, F., Martin, S., Sultana, R., Mancuso, C., … Butterfield, D. (2011). Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. Pharmacological Research, 63(3), 172-80. https://doi.org/10.1016/j.phrs.2010.12.007

Martin, S., Cenini, G., Barone, E., Dowling, A., Mancuso, C., Butterfield, D., … Head, E. (2011). Coenzyme Q10 and cognition in atorvastatin treated dogs. Neuroscience Letters, 501(2), 92-5. https://doi.org/10.1016/j.neulet.2011.06.054 (Original work published 2011)